Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors — Stella

Recruiting

Back to Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(21 sites)

France

CHU Amiens - Hôpital Sud, Amiens

Radiothérapie, CLCC François Baclesse, Caen

Radiothérapie, CRLCC Jean Perrin, Clermont-Ferrand

Radiothérapie, CRLCC GF Leclerc, Dijon

Radiothérapie, Hôpital A. Michallon, CHU de Grenoble, Grenoble

Key details

Sponsor

Hospices Civils de Lyon

Enrollment target

~250 participants

Started

December 2017

Primary completion

December 2026

Age range

18 Years and older

Last updated September 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov